Antonios Tavernarakis

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

Alison Halliday, Richard Bulbulia, Leo H. Bonati et al. · The Lancet · 2021 · 290 citations · Full text

Predicting 30-Day Case Fatality of Primary Inoperable Intracerebral Hemorrhage Based on Findings at the Emergency Department

Panagiotis Zis, Pavlos Leivadeas, Dimitrios Michas et al. · Journal of Stroke and Cerebrovascular Diseases · 2014 · 34 citations

Critical Care Management, Medicine, Patient Safety +7

Patient dose in cardiac radiology.

Andreas Stratis, Prodromos Anthopoulos, Isidoros P. Gavaliatsis et al. · PubMed · 2009 · 34 citations

Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases

Maria Michalopoulou, Chryssoula Nikolaou, Antonios Tavernarakis et al. · Immunology Letters · 2004 · 33 citations

Immunology, Social Sciences, Neuroinflammation +16